Researchers Develop Metal-Enhanced Fluorescence Probes for Influenza Detection
Researchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
Researchers demonstrated that metal-enhanced fluorescence probes could rapidly detect influenza virus proteins without complex lab equipment.
BD received Emergency Use Authorization from the US FDA for a new molecular diagnostic combination test for respiratory viruses.
Currently circulating mutant strain variants of influenza are detectable through Cepheid's respiratory tests.
Scientists created a face mask that detects common respiratory viruses, like influenza and COVID, in the air in droplets or aerosols.
Read MoreA new report that detailed how RDTs for influenza used by individuals at home could potentially expand access to testing.
Read MorePreliminary clinical study results for Lucira’s COVID-19 & Flu test demonstrated similar sensitivity and specificity to lab-based PCR assays.
Read MoreVisby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read MoreHome-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings.
Read MoreCompass Laboratory Services recently detected two cases of simultaneous infection by the SARS-CoV-2 virus and Influenza A.
Read MoreApplied BioCode has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its BioCode CoV-2 Flu Plus Assay.
Read MoreThe Aptima SARS-CoV-2/Flu Assay from Hologic tests simultaneously for SARS-CoV-2, influenza A, and influenza B on the Panther molecular diagnostics system.
Read MoreLumiraDx has submitted the LumiraDx SARS-CoV-2 & Flu A/B Test to the FDA for Emergency Use Authorization (EUA).
Read MoreIn 2021, as new COVID cases continue, labs could experience the perfect storm of testing for SARS-CoV-2, influenza A and B, and RSV at the same time.
Read MoreGENETWORx provides a combination COVID/influenza/RSV test, and is able to provide follow-up PCR testing after a positive test in 24-48 hours.
Read MoreThe cold and flu viruses that many have avoided while staying at home and social distancing during the COVID-19 pandemic will likely run rampant again as masks come off and schools reopen, reports STAT News.
Read MoreGT Molecular has started shipping its sensitive PCR tests to monitor the coronavirus Delta variant (B.1.617.2) as well as testing and PCR kits for the detection of Influenza A and B.
Read MoreResearchers showed that their testing technology can accurately distinguish between a viral and a bacterial infection for respiratory illness and the test provided results in under an hour.
Read MoreTesting integrates the Spectrum Solutions saliva self-collection system with a new, advanced multiplex qPCR platform for the simultaneous RNA detection of covid-19 and its viral mutations, as well as Influenza A, B, and more.
Read More